AzTrials
AzTrials

Knee OsteoarthritisNCT05529914

Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis

A study testing Myofascial release, Neuromuscular exercises and Cold pack in people with Knee Osteoarthritis and Pes Anserine Bursitis, run by Dow University of Health Sciences at 2 sites in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized control trial will be conducted at the outpatient department of Dow Institute of Physical Medicine and Rehabilitation. A sample size of 80 is calculated using PASS version 11 software. The subjects will be first screened and those who fulfill the inclusion criteria, will be asked to fill the consent form. Read more about this study

Who is it for?
Ages 40 to 60 years
Conditions the study is for
Knee Osteoarthritis, Pes Anserine Bursitis
What is being tested?
Myofascial release, Neuromuscular exercises and Cold pack
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
2 sitesPakistan
Study dates
27 Sep 2022to 30 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Male and Females both with the age between 40-60 years.
  • Patients with unilateral or bilateral knee osteoarthritis with pes anserine syndrome.
  • Patients with knee pain more than 3.4 cm on visual analogue scale as minimum cut of value.
  • Kellgren and Lawrence grade II and III on radiological findings.
  • Duration of knee osteoarthritis more than 3 months (chronic).

Who cannot join

  • Patients with any neurological disorder.
  • Knee deformities such as contractures, genu valgum and genu varum.
  • Septic knee arthritis.
  • History of ligamentous injury or meniscal tear.
  • Cancer or any other malignancy or bone tumor.
  • Any history of previous lower limb arthroplasty or other knee surgery.
  • Comorbid like diabetes mellitus.
  • Inflammatory rheumatic disease (R.A).

Trial locations and contacts

2 sites in 1 country.

Pakistan2 sites
  • Dow Institute of Physical Medicine and Rehabilitation

    Karachi, Sindh, 74200

  • Sindh Institute of Physical Medicine and Rehabilitation

    Karachi, Sindh, 74200

Other trials in Pakistan

About this study

Official title: Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis: A Randomized Control Trial

A randomized control trial will be conducted at the outpatient department of Dow Institute of Physical Medicine and Rehabilitation. A sample size of 80 is calculated using PASS version 11 software. The subjects will be first screened and those who fulfill the inclusion criteria, will be asked to fill the consent form. After selection, the participants will be randomly allocated by the help of computer generated randomization sheet, into two groups i.e. experimental and the control group. The group A will be provided with the myofascial release along with the neuromuscular training whereas the group B will only receive the neuromuscular training. Cold pack will be applied to both the groups. The neuromuscular training consists of warm-up phase, lunges, sideways exercises, wall squats, weight transfer exercises, step up and down and the cool down phase. Total 12 sessions of 35 minutes each will be given to all the participants for about 4 weeks on alternate days. Outcome measures will be analyzed by visual analogue scale (VAS) for pain assessment, goniometry for range of motion and the Knee injury and Osteoarthritis Outcome Score (KOOS) to evaluate the functional assessment of the patients at the baseline and the post intervention.

Being tested
Myofascial release, Neuromuscular exercises, Cold pack
Medical subject headings
Osteoarthritis, Knee, Bursitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Myofascial releaseOther

    It is a type of physical therapy often used to treat myofascial pain syndrome with pressure.

  • Neuromuscular exercisesOther

    Exercises commonly utilized in neuromuscular training programs to improve strength, balance , speed and agility. It will comprised of Warm-up, Lunges, Sideways exercises, Wall squats, Weight transfer exercise, Step up \& down, Cool-down

  • Cold packOther

    Also called Cold pack therapy

    Application of cold pack around the patient's body, and covered with dry towel

Study groups in NCT05529914
Study groupRoleWhat they receive
Myofascial release + Neuromuscular exercises + Cold packExperimentalNot described
Receives: Other: Myofascial release; Other: Neuromuscular exercises; Other: Cold pack
Neuromuscular exercises + Cold packActive comparatorNot described
Receives: Other: Neuromuscular exercises; Other: Cold pack

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain intensity on visual analogue scale after four weeks

    The Visual Analogue Scale is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between pains with similar conditions.. It is 0 to 10 cm scale. Patients rate their pain on that scale. Higher the score in centimeter, severe will be the pain experienced.

    Measured: Baseline and 4 weeks

  2. Change in range of motion assessed with universal goniometer after four weeks

    The Goniometer is an instrument for the precise measurement of range of movement angles in degree , especially one used to measure the angles before and after range of motion.. Increase in the degree of angle suggests increase in range of movement.

    Measured: Baseline and 4 weeks

Secondary outcomes (1)
  1. Change in functional disability assessed with Knee injury and osteoarthritis outcome score after four weeks.

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a knee-specific instrument, developed to assess the patients' opinion about their knee and associated problems regarding functional disability. In consists of total 100 scores. Increase in scores suggests decreased functional disability and decrease in scores suggests increased functional disability.

    Measured: Baseline and 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Sep 2022
  2. Study start27 Sep 2022
  3. Primary completion30 Mar 2023
  4. Study completion30 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05529914
Sponsor's protocol ID
RHassan
Status last verified
Jan 2024
First submitted
3 Sep 2022
Last updated
9 Jan 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Myofascial release, Neuromuscular exercises and Cold pack in people with Knee Osteoarthritis and Pes Anserine Bursitis, run by Dow University of Health Sciences at 2 sites in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain intensity on visual analogue scale after four weeks (time frame: Baseline and 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in